On this page
Desoximetasone
Overview
Active ingredients
Source: NDC DirectoryForms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Corticosteroid Hormone Receptor Agonists [MoA] | MoA | All 215 members |
| Corticosteroid [EPC] | EPC | All 215 members |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 077770-001 | DESOXIMETASONE | OINTMENT | DESOXIMETASONE | Prescription | AB |
Therapeutic equivalence
Source: Orange BookWhat this rating means: Therapeutically equivalent — bioequivalence demonstrated by in vivo or in vitro testing
Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Original application | 1 | Approved | April 20, 2015 | — |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20251125). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingINDICATIONS AND USAGE Desoximetasone Ointment USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and Administration
openFDA Drug LabelingDOSAGE AND ADMINISTRATION Apply a thin film of Desoximetasone Ointment USP, 0.05% to the affected skin areas twice daily. Rub in gently.
Contraindications
openFDA Drug LabelingCONTRAINDICATIONS Desoximetasone Ointment USP, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Warnings
openFDA Drug LabelingWARNINGS Keep out of reach of children.
Adverse Reactions
openFDA Drug LabelingADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. In controlled clinical studies the incidence of adverse reactions was low (0.2%) for Desoximetasone Ointment USP, 0.05% and included mild burning sensation at the site of application. To report SUSPECTED ADVERSE REACTIONS , contact The J. Molner Company LLC at 1-800-552-8750 and/or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Description
openFDA Drug LabelingDESCRIPTION Desoximetasone Ointment USP, 0.25% contains the active synthetic corticosteroid desoximetasone. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Each gram of Desoximetasone Ointment USP, 0.25% contains 2.5 mg of desoximetasone in an ointment base consisting of fractionated coconut oil and white petrolatum. The chemical name of desoximetasone is Pregna-1, 4-diene-3, 20-dione, 9-fluoro-11, 21-dihydroxy-16-methyl-,(11b,16α)-. Desoximetasone has the molecular formula C 22 H 29 FO 4 and a molecular weight of 376.47. The CAS Registry Number is 382-67-2. The structural formula is: structured product formula for Desoximetasone
Overdosage
openFDA Drug LabelingOVERDOSAGE Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS ).
How Supplied / Storage and Handling
openFDA Drug LabelingHOW SUPPLIED Desoximetasone ointment USP, 0.05% is supplied as follows: 60 gram tubes: NDC 68180-948-04 Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. ® The brands listed are trademarks of their respective owners and are not trademarks of Lupin Pharmaceuticals, Inc. The makers of these brands are not affiliated with and do not endorse Lupin Pharmaceuticals, Inc. or its products. LUPIN and the are registered trademarks of Lupin Pharmaceuticals, Inc. Manufactured for: Lupin Pharmaceuticals, Inc. Naples, FL 34108 United States Manufactured by: Lupin Limited Pithampur (M.P.) – 454 775 India December 2024 ID#: 277875 Image
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: DESOXIMETASONE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 0472-0479-15 | 0472-0479 | Actavis Pharma, Inc. | 1 TUBE in 1 CARTON (0472-0479-15) / 15 g in 1 TUBE | November 21, 2016 |
| 0472-0479-60 | 0472-0479 | Actavis Pharma, Inc. | 1 TUBE in 1 CARTON (0472-0479-60) / 60 g in 1 TUBE | November 21, 2016 |
| 63629-8641-1 | 63629-8641 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (63629-8641-1) / 15 g in 1 TUBE | May 14, 2015 |
| 63629-8642-1 | 63629-8642 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (63629-8642-1) / 60 g in 1 TUBE | June 16, 2015 |
| 72162-1414-2 | 72162-1414 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-1414-2) / 15 g in 1 TUBE | August 17, 2023 |
| 72162-1414-6 | 72162-1414 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-1414-6) / 60 g in 1 TUBE | August 17, 2023 |
| 72162-2629-1 | 72162-2629 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-2629-1) / 100 g in 1 TUBE | April 23, 2026 |
| 72162-2629-6 | 72162-2629 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-2629-6) / 60 g in 1 TUBE | April 23, 2026 |
| 68462-531-17 | 68462-531 | Glenmark Pharmaceuticals Inc., USA | 15 g in 1 TUBE (68462-531-17) | September 20, 2013 |
| 68462-531-65 | 68462-531 | Glenmark Pharmaceuticals Inc., USA | 60 g in 1 TUBE (68462-531-65) | September 20, 2013 |
| 68180-946-01 | 68180-946 | Lupin Pharmaceuticals, Inc. | 1 TUBE in 1 CARTON (68180-946-01) / 15 g in 1 TUBE | May 10, 2017 |
| 68180-946-04 | 68180-946 | Lupin Pharmaceuticals, Inc. | 1 TUBE in 1 CARTON (68180-946-04) / 60 g in 1 TUBE | May 10, 2017 |
| 68180-948-04 | 68180-948 | Lupin Pharmaceuticals, Inc. | 1 TUBE in 1 CARTON (68180-948-04) / 60 g in 1 TUBE | April 25, 2017 |
| 40032-024-60 | 40032-024 | Novel Laboratories, Inc. | 1 TUBE in 1 CARTON (40032-024-60) / 60 g in 1 TUBE | May 10, 2016 |
| 40032-024-61 | 40032-024 | Novel Laboratories, Inc. | 1 TUBE in 1 CARTON (40032-024-61) / 15 g in 1 TUBE | May 10, 2016 |
| 45802-496-14 | 45802-496 | Padagis Israel Pharmaceuticals Ltd | 1 TUBE in 1 CARTON (45802-496-14) / 15 g in 1 TUBE | May 14, 2015 |
| 45802-496-96 | 45802-496 | Padagis Israel Pharmaceuticals Ltd | 1 TUBE in 1 CARTON (45802-496-96) / 60 g in 1 TUBE | June 16, 2015 |
| 51672-1262-1 | 51672-1262 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1262-1) / 15 g in 1 TUBE | June 7, 1996 |
| 51672-1262-2 | 51672-1262 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1262-2) / 30 g in 1 TUBE | June 7, 1996 |
| 51672-1262-3 | 51672-1262 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1262-3) / 60 g in 1 TUBE | June 7, 1996 |
| 51672-1262-7 | 51672-1262 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1262-7) / 100 g in 1 TUBE | June 7, 1996 |
| 51672-1352-1 | 51672-1352 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1352-1) / 15 g in 1 TUBE | January 17, 1985 |
| 51672-1352-2 | 51672-1352 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1352-2) / 30 g in 1 TUBE | January 17, 1985 |
| 51672-1352-3 | 51672-1352 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1352-3) / 60 g in 1 TUBE | January 17, 1985 |
| 51672-1352-7 | 51672-1352 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1352-7) / 100 g in 1 TUBE | January 17, 1985 |
| 83148-021-60 | 83148-021 | The J. Molner Company LLC | 1 TUBE in 1 CARTON (83148-021-60) / 60 g in 1 TUBE | February 1, 2025 |
| 83148-021-99 | 83148-021 | The J. Molner Company LLC | 1 TUBE in 1 CARTON (83148-021-99) / 100 g in 1 TUBE | May 1, 2025 |
| 72578-095-01 | 72578-095 | Viona Pharmaceuticals Inc | 1 TUBE in 1 CARTON (72578-095-01) / 15 g in 1 TUBE | October 23, 2020 |
| 72578-095-02 | 72578-095 | Viona Pharmaceuticals Inc | 1 TUBE in 1 CARTON (72578-095-02) / 60 g in 1 TUBE | October 23, 2020 |
| 72578-095-03 | 72578-095 | Viona Pharmaceuticals Inc | 1 TUBE in 1 CARTON (72578-095-03) / 100 g in 1 TUBE | October 23, 2020 |
| 70771-1166-0 | 70771-1166 | Zydus Lifesciences Limited | 1 TUBE in 1 CARTON (70771-1166-0) / 100 g in 1 TUBE | December 5, 2017 |
| 70771-1166-1 | 70771-1166 | Zydus Lifesciences Limited | 1 TUBE in 1 CARTON (70771-1166-1) / 15 g in 1 TUBE | December 5, 2017 |
| 70771-1166-3 | 70771-1166 | Zydus Lifesciences Limited | 1 TUBE in 1 CARTON (70771-1166-3) / 60 g in 1 TUBE | December 5, 2017 |
| 0472-0479 | 0472-0479 | Actavis Pharma, Inc. | — | November 21, 2016 |
| 63629-8641 | 63629-8641 | Bryant Ranch Prepack | — | May 14, 2015 |
| 63629-8642 | 63629-8642 | Bryant Ranch Prepack | — | May 14, 2015 |
| 72162-1414 | 72162-1414 | Bryant Ranch Prepack | — | May 14, 2015 |
| 72162-2629 | 72162-2629 | Bryant Ranch Prepack | — | February 1, 2025 |
| 68462-531 | 68462-531 | Glenmark Pharmaceuticals Inc., USA | — | September 20, 2013 |
| 68180-946 | 68180-946 | Lupin Pharmaceuticals, Inc. | — | May 10, 2017 |
| 68180-948 | 68180-948 | Lupin Pharmaceuticals, Inc. | — | April 25, 2017 |
| 40032-024 | 40032-024 | Novel Laboratories, Inc. | — | May 10, 2016 |
| 45802-496 | 45802-496 | Padagis Israel Pharmaceuticals Ltd | — | May 14, 2015 |
| 51672-1262 | 51672-1262 | Sun Pharmaceutical Industries, Inc. | — | June 7, 1996 |
| 51672-1352 | 51672-1352 | Sun Pharmaceutical Industries, Inc. | — | January 17, 1985 |
| 83148-021 | 83148-021 | The J. Molner Company LLC | — | February 1, 2025 |
| 72578-095 | 72578-095 | Viona Pharmaceuticals Inc | — | October 23, 2020 |
| 70771-1166 | 70771-1166 | Zydus Lifesciences Limited | — | December 5, 2017 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Orange Book | FDA | Therapeutic equivalence codes, reference drug flags, patents, exclusivity |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
Generated September 25, 2026 · 12 sections on this page.